YU68299A - Preparati rastvorenog sertralina - Google Patents
Preparati rastvorenog sertralinaInfo
- Publication number
- YU68299A YU68299A YU68299A YU68299A YU68299A YU 68299 A YU68299 A YU 68299A YU 68299 A YU68299 A YU 68299A YU 68299 A YU68299 A YU 68299A YU 68299 A YU68299 A YU 68299A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- compositions
- solubilized
- solubilized sertraline
- sertraline compositions
- sertraline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Predmetni preparat koji sadrži sertalin i agens rastvaranja koji povećava rastvorljivost sertralina u vodenim ambijentima primene koji sadrže hlorid jon.[Compositions of matter comprising sertraline and a solubilizing agent which increases the solubility of sertraline in aqueous chloride ion-containing use environments.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5141397P | 1997-07-01 | 1997-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU68299A true YU68299A (sh) | 2002-06-19 |
Family
ID=21971159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU68299A YU68299A (sh) | 1997-07-01 | 1998-06-15 | Preparati rastvorenog sertralina |
Country Status (34)
Country | Link |
---|---|
EP (1) | EP0999829A1 (sh) |
JP (1) | JP2000514100A (sh) |
KR (1) | KR100366373B1 (sh) |
CN (1) | CN1261794A (sh) |
AP (1) | AP1192A (sh) |
AR (3) | AR015917A1 (sh) |
AU (1) | AU742535B2 (sh) |
BG (1) | BG103918A (sh) |
BR (1) | BR9810739A (sh) |
CA (1) | CA2290974C (sh) |
CO (1) | CO4940495A1 (sh) |
DZ (1) | DZ2548A1 (sh) |
EA (1) | EA002481B1 (sh) |
HN (1) | HN1998000102A (sh) |
HR (1) | HRP980377A2 (sh) |
HU (1) | HUP0002236A3 (sh) |
ID (1) | ID23429A (sh) |
IL (1) | IL133076A (sh) |
IS (1) | IS5260A (sh) |
MA (1) | MA24587A1 (sh) |
NO (1) | NO996520L (sh) |
OA (1) | OA11243A (sh) |
PA (1) | PA8454301A1 (sh) |
PE (1) | PE97199A1 (sh) |
PL (1) | PL337804A1 (sh) |
SK (1) | SK181099A3 (sh) |
TN (1) | TNSN98124A1 (sh) |
TR (1) | TR199903297T2 (sh) |
TW (1) | TW550087B (sh) |
UA (1) | UA67741C2 (sh) |
UY (1) | UY25071A1 (sh) |
WO (1) | WO1999001120A1 (sh) |
YU (1) | YU68299A (sh) |
ZA (1) | ZA985708B (sh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU43702A (sh) | 1999-12-23 | 2004-11-25 | Pfizer Products Inc. | Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka |
US20030086972A1 (en) * | 2000-08-09 | 2003-05-08 | Appel Leah E. | Hydrogel-driven drug dosage form |
AU2001276608A1 (en) | 2000-08-30 | 2002-03-13 | Pfizer Products Inc. | Sustained release formulations for growth hormone secretagogues |
US20040191207A1 (en) * | 2003-03-31 | 2004-09-30 | Lipari John M. | Alpha-hydroxy acid ester drug delivery compositions and methods of use |
JP2010520897A (ja) * | 2007-03-12 | 2010-06-17 | ディーエスエム アイピー アセッツ ビー.ブイ. | 化粧品組成物 |
US20120289517A1 (en) * | 2009-12-29 | 2012-11-15 | Kowa Co., Ltd. | Solid pharmaceutical composition for oral administration |
CN102711763A (zh) * | 2009-12-29 | 2012-10-03 | 兴和株式会社 | 口服用医药组合物 |
CN109908354A (zh) * | 2017-12-12 | 2019-06-21 | 万特制药(海南)有限公司 | 盐酸舍曲林口服浓缩液及其制备工艺 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4803076A (en) * | 1986-09-04 | 1989-02-07 | Pfizer Inc. | Controlled release device for an active substance |
EP0415612B1 (en) * | 1989-08-30 | 1993-11-10 | Pfizer Inc. | Use of sertraline for the treatment of chemical dependencies |
ZA97976B (en) * | 1996-04-05 | 1997-08-18 | Alza Corp | Uniform drug delivery theraphy. |
-
1998
- 1998-06-15 JP JP11506774A patent/JP2000514100A/ja active Pending
- 1998-06-15 SK SK1810-99A patent/SK181099A3/sk unknown
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/xx unknown
- 1998-06-15 CN CN98806763A patent/CN1261794A/zh active Pending
- 1998-06-15 EA EA199900962A patent/EA002481B1/ru unknown
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/hu unknown
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/pt not_active Application Discontinuation
- 1998-06-15 PL PL98337804A patent/PL337804A1/xx unknown
- 1998-06-15 CA CA002290974A patent/CA2290974C/en not_active Expired - Fee Related
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/en not_active Application Discontinuation
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-15 YU YU68299A patent/YU68299A/sh unknown
- 1998-06-15 EP EP98923019A patent/EP0999829A1/en not_active Withdrawn
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/ko not_active IP Right Cessation
- 1998-06-15 UA UA99116391A patent/UA67741C2/uk unknown
- 1998-06-15 IL IL13307698A patent/IL133076A/xx not_active IP Right Cessation
- 1998-06-15 ID IDW991701A patent/ID23429A/id unknown
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-25 TW TW087110267A patent/TW550087B/zh active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/es not_active Application Discontinuation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/es unknown
- 1998-06-29 AR ARP980103146A patent/AR015917A1/es not_active Application Discontinuation
- 1998-06-29 UY UY25071A patent/UY25071A1/es not_active IP Right Cessation
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/fr unknown
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/xx unknown
- 1998-06-30 MA MA25146A patent/MA24587A1/fr unknown
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/xx active
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/hr not_active Application Discontinuation
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/es unknown
- 1998-07-01 CO CO98037137A patent/CO4940495A1/es unknown
-
1999
- 1999-11-19 IS IS5260A patent/IS5260A/is unknown
- 1999-11-23 BG BG103918A patent/BG103918A/xx unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/no not_active Application Discontinuation
-
2003
- 2003-06-19 AR ARP030102180A patent/AR040280A2/es unknown
- 2003-06-19 AR ARP030102179A patent/AR040279A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2365772A (en) | Factor | |
GB9717905D0 (en) | Lipid-containing compositions and uses thereof | |
ZA995601B (en) | Water-soluble pharmaceutical composition in an ionic complex and the use thereof. | |
EP1017427A4 (en) | BIOCIDES COMBINED CHELATORS: MICROBIOLOGICALLY INDUCED BIOFILM TREATMENT AND CORROSION | |
HUP0103267A3 (en) | High-strength aqueous glyphosate concentrate and use thereof | |
EP0680694A3 (en) | Composition of fluorescent biocides for use in aqueous systems. | |
AU3117397A (en) | Fire-fighting agents containing polysaccharides and fluorochemical oligomeric surfactants | |
NZ239879A (en) | Cleansing composition comprising two amphoteric surfactants-one being an imidazolinium derivative, the other an aminoalkanoate or iminodialkanoate, and an insoluble conditioning agent | |
ATE279142T1 (de) | Bodenbearbeitungsmaschine | |
AU7597898A (en) | Use of isoflavonoids in the treatment or prevention of postpartum depression | |
YU68299A (sh) | Preparati rastvorenog sertralina | |
HUP0103636A3 (en) | 2-methyl-thieno-benzodiazepine formulation and its use | |
ZA200102956B (en) | Use of ophthalmic composition comprising vitamin A and Vitamin E. | |
AU1887399A (en) | Aqueous compositions comprising complexing agents and uses therof | |
IL126185A0 (en) | Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs | |
AU2600499A (en) | Methods and compositions comprising the use of blocked b-amyloid peptide | |
HK1039140A1 (zh) | 塗布劑及其用途 | |
BG104914A (en) | Paroxetine maleate | |
MY119728A (en) | Encapsulated solution dosage forms of sertraline | |
EP0657522A3 (en) | Salt compositions and their use in functional liquids. | |
GB9802542D0 (en) | New use | |
MD980129A (en) | Antiherpetic remedy | |
PL347545A1 (en) | Case-safe system | |
HUP0103040A3 (en) | High - level source and it's application | |
ECSP982572A (es) | Composiciones solubilizadas de sertralina |